These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9098877)

  • 1. Physiologically based pharmacokinetic models of 2',3'-dideoxyinosine.
    Kang HJ; Wientjes MG; Au JL
    Pharm Res; 1997 Mar; 14(3):337-44. PubMed ID: 9098877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic interaction between intravenous 2',3'-dideoxyinosine and pentamidine in rats.
    Yeh TK; Kang HJ; Wientjes MG; Au JL
    Pharm Res; 1996 Apr; 13(4):628-32. PubMed ID: 8710758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue pharmacokinetics of 2',3'-dideoxyinosine in rats.
    Kang HJ; Wientjes MG; Au JL
    Biochem Pharmacol; 1994 Nov; 48(11):2109-16. PubMed ID: 7802702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ciprofloxacin on the disposition of 14C-dideoxyinosine-derived radioactivity in the rat.
    Gallicano KD; Buttar HS; Moffatt JH
    Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):163-74. PubMed ID: 8321920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic targeting of anti-HIV nucleosides: distribution of 2',3'-dideoxyinosine after intravenous and oral administration of dipalmitoylphosphatidyl prodrug in mice.
    Manouilov KK; Xu ZS; Boudinot FD; Schinazi RF; Chu CK
    Antiviral Res; 1997 May; 34(3):91-9. PubMed ID: 9191016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose dependence in the plasma pharmacokinetics and uptake kinetics of 2',3'-dideoxyinosine into brain and cerebrospinal fluid of rats.
    Hoesterey BL; Galinsky RE; Anderson BD
    Drug Metab Dispos; 1991; 19(5):907-12. PubMed ID: 1686234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of drug kinetics in dermis to predict in vivo blood concentration after topical application.
    Gao X; Wientjes MG; Au JL
    Pharm Res; 1995 Dec; 12(12):2012-7. PubMed ID: 8786981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel physiologically based pharmacokinetic modeling of patupilone for human pharmacokinetic predictions.
    Xia B; Heimbach T; Lin TH; He H; Wang Y; Tan E
    Cancer Chemother Pharmacol; 2012 Jun; 69(6):1567-82. PubMed ID: 22526410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive absorption of 2',3'-dideoxyinosine by intratracheal administration in rats.
    Gao X; Wientjes MG; Au JL
    Pharm Res; 1995 Dec; 12(12):1901-6. PubMed ID: 8786964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced physiologically-based pharmacokinetic model of dabigatran etexilate-dabigatran and its application for prediction of intestinal P-gp-mediated drug-drug interactions.
    Lang J; Vincent L; Chenel M; Ogungbenro K; Galetin A
    Eur J Pharm Sci; 2021 Oct; 165():105932. PubMed ID: 34260894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distributed model analysis of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine distribution in brain tissue and cerebrospinal fluid.
    Takasawa K; Terasaki T; Suzuki H; Ooie T; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1509-17. PubMed ID: 9316866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration kinetics of 2',3'-dideoxyinosine in dermis is described by the distributed model.
    Gupta E; Wientjes MG; Au JL
    Pharm Res; 1995 Jan; 12(1):108-12. PubMed ID: 7724469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a physiologically based pharmacokinetic model for perchloroethylene using tissue concentration-time data.
    Dallas CE; Chen XM; O'Barr K; Muralidhara S; Varkonyi P; Bruckner JV
    Toxicol Appl Pharmacol; 1994 Sep; 128(1):50-9. PubMed ID: 8079354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system targeting of 2',3'-dideoxyinosine via adenosine deaminase-activated 6-halo-dideoxypurine prodrugs.
    Morgan ME; Chi SC; Murakami K; Mitsuya H; Anderson BD
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2156-65. PubMed ID: 1444295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of brain tissue localized purine metabolizing enzymes in the central nervous system delivery of anti-HIV agents 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
    Singhal D; Morgan ME; Anderson BD
    Pharm Res; 1997 Jun; 14(6):786-92. PubMed ID: 9210198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of didanosine and ketoconazole after coadministration to patients seropositive for the human immunodeficiency virus.
    Knupp CA; Brater DC; Relue J; Barbhaiya RH
    J Clin Pharmacol; 1993 Oct; 33(10):912-7. PubMed ID: 8227460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of 2',3'-dideoxyinosine in monkeys.
    Qian MX; Finco TS; Swagler AR; Gallo JM
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1247-9. PubMed ID: 1929275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral absorption of anti-aids nucleoside analogues: 3. Regional absorption and in vivo permeability of 2',3'-dideoxyinosine in an intestinal-vascular access port (IVAP) dog model.
    Sinko PJ; Sutyak JP; Leesman GD; Hu P; Makhey VD; Yu H; Smith CL
    Biopharm Drug Dispos; 1997 Nov; 18(8):697-710. PubMed ID: 9373726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonlinear disposition of intravenous 2',3'-dideoxyinosine in rats.
    Wientjes MG; Mukherji E; Au JL
    Pharm Res; 1992 Aug; 9(8):1070-5. PubMed ID: 1409380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions.
    Greupink R; Schreurs M; Benne MS; Huisman MT; Russel FG
    Eur J Pharm Sci; 2013 Aug; 49(5):819-28. PubMed ID: 23806476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.